152530-08-0

Basic information

• Product Name: 5-(2-aminoethyl)-8-hydroxy-4-oxo-1H-quinoline-3-carbonitrile
• Synonyms: 5-(2-aminoethyl)-8-hydroxy-4-oxo-1H-quinoline-3-carbonitrile;3-Quinolinecarbonitrile, 5-(2-aMinoethyl)-1,4-dihydro-8-hydroxy-4-oxo-
• CAS NO: 152530-08-0
• Molecular Formula: C₁₂H₁₁N₃O₂
• Molecular Weight: 229.23
• Mol File: 152530-08-0.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 445.4°C at 760 mmHg
• Flash Point: 223.2°C
• Density: 1.41g/cm³
• Vapor Pressure: 1.51E-08mmHg at 25°C
• Refractive Index: 1.679
• CAS DataBase Reference: 5-(2-aminoethyl)-8-hydroxy-4-oxo-1H-quinoline-3-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(2-aminoethyl)-8-hydroxy-4-oxo-1H-quinoline-3-carbonitrile(152530-08-0)
• EPA Substance Registry System: 5-(2-aminoethyl)-8-hydroxy-4-oxo-1H-quinoline-3-carbonitrile(152530-08-0)

Safety Data

• Hazardous Substances Data: 152530-08-0(Hazardous Substances Data)

Upstream product

• 81654-49-1 N-[2-(3-amino-4-methoxyphenyl)ethyl]-2,2,2-trifluoro acetamide 
• 152530-19-3 5-(2-trifluoroacetamidoethyl)-8-methoxy-3-cyano-4-quinolone 

Relevant articles and documents

Synthesis and pharmacological evaluation of tyramine congeners containing fused heterocyclic rings

A series of tyramine congeners carrying a fused heterocyclic ring were synthesized with the aim of combining the positive inotropic effect of the cardiac phosphodiesterase III inhibitors with the vasodilatory effect of heterocyclic dopamine receptor agoni